ITF 1697
Latest Information Update: 16 Jul 2016
At a glance
- Originator Italfarmaco
- Class Anti-ischaemics; Oligopeptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Reperfusion injury
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Reperfusion-injury in Italy (IV)
- 06 Mar 2008 Preclinical trials in Reperfusion injury in Italy (IV)
- 14 Jun 2004 Phase-II clinical trials in Reperfusion injury in Europe (IV)